LUGPA Policy Brief: CMS Strengthens Budget Neutrality Standards for Medicaid Section 1115 Demonstrations

June 2026   

At-a-Glance Essentials

What's Changing
On June 11, 2026, CMS issued State Medicaid Director Letter #26-003 announcing stricter budget neutrality requirements for Medicaid Section 1115 demonstrations. Beginning January 1, 2027, the CMS Chief Actuary must certify that new demonstrations, renewals, and amendments will not increase federal Medicaid spending compared to what spending would have been without the waiver.

Section 1115 demonstrations allow states to test innovative approaches to coverage, care delivery, and payment models. The new requirements were mandated by the Working Families Tax Cut Act (P.L. 119-21) and establish budget neutrality as a statutory requirement rather than a policy expectation.

Key Provisions

• Actuarial Certification: The CMS Chief Actuary must certify that demonstrations do not increase federal Medicaid spending.
• Stronger Fiscal Oversight: Demonstrations that increase federal costs will not be approved.
• Focus on Innovation: CMS will prioritize initiatives that test new approaches not otherwise available under Medicaid authorities.
• State Flexibility with Accountability: States retain the ability to innovate but must demonstrate measurable value and cost neutrality.
• Implementation Timeline: New standards apply beginning January 1, 2027, while CMS pursues formal rulemaking.

Why It Matters

Section 1115 demonstrations account for a significant share of Medicaid spending and have been used to expand eligibility, benefits, value-based payment models, and care coordination programs. The new requirements are intended to strengthen fiscal accountability and ensure that Medicaid innovations improve outcomes without increasing federal costs.

While the changes may improve long-term program sustainability, they could also limit states' ability to pursue certain high-cost or expansive demonstration projects.

Potential Impact on LUGPA Members

Many LUGPA practices serve Medicaid beneficiaries and participate in programs supported by Section 1115 demonstrations.

Potential Opportunities

• Greater emphasis on value-based care and cost savings may favor integrated specialty care models that improve outcomes while reducing overall costs.
• Demonstrations focused on care coordination, outpatient treatment, and reducing avoidable hospitalizations may align well with independent urology practices.

Potential Challenges

• States may face greater difficulty implementing or expanding demonstrations involving specialty care, telehealth, or enhanced benefits.
• Existing demonstrations could be modified, delayed, or scaled back if they cannot meet the new budget neutrality requirements.
• Reduced state flexibility could affect reimbursement policies, participation incentives, or patient access initiatives.

LUGPA Position

LUGPA supports policies that promote fiscal responsibility while preserving patient access to specialty care and protecting the viability of independent physician practices. Medicaid innovation should encourage high-value, cost-effective care without creating unnecessary barriers to patient access.

Recommended Actions

• Monitor state Medicaid waiver activity and renewal proposals.
• Share data demonstrating the value and cost-effectiveness of integrated urologic care.
• Evaluate potential impacts on Medicaid programs in your state.
• Engage with LUGPA advocacy efforts and future CMS rulemaking opportunities.

Bottom Line

CMS's new budget neutrality framework represents a significant shift in Medicaid waiver oversight. While the policy is intended to strengthen accountability and protect federal resources, it may also limit some state-led innovation efforts. LUGPA will continue monitoring implementation and advocating for policies that support independent specialty practices and patient access to high-quality urologic care.

For More Information:
CMS State Medicaid Director Letter #26-003